← Back to front page
United States · Exchanges & live quotes · Nasdaq

Cocrystal Pharma Posts Wider Q3 Loss, Led By Norovirus Challenge Study Costs

Published by Nasdaq · United States 1 h ago

Detailed summary

(RTTNews) - Cocrystal Pharma, Inc. (COCP), a clinical stage biotechnology firm, on Sunday reported a wider loss in its third quarter, driven by higher clinical trial and related…

Read the full article on Nasdaq Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)

Also worth reading